USPTO serial 79328678
NUMBER 2
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 24, 2023
- Examiner
- BETTS, MARCYA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NUMBER 2?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
P. Jay Hines
P. Jay Hines MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 LEGATO RD SUITE 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices for use in diagnosing and treating gastrointestinal diseases; medical apparatus and instruments for collecting and storing human faeces; medical apparatus and instruments for administering gastrointestinal medicine; medical instruments for analysing gut health being bacteria in humans or animals; medical instruments for analysing human excreta or animal excreta; medical instruments for analysing biological and physiological data being gut bacteria, yeast, parasites, immune function and digestive capacity in humans and animals; medical apparatus for introducing pharmaceutical preparations into the human body; gloves for medical examinations; bags adapted for medical use, namely bags for collecting and storing human waste, medical waste and bags for collecting and storing samples of human waste; parts and fittings for medical apparatus, medical devices and medical instruments, namely, parts and fittings for sample collection devices for medical diagnostic uses being shaped padding for supporting parts of the body parts and fittings for apparatus for taking samples of human waste being bags for collecting body fluids, none of the aforementioned parts and fittings being parts and fittings for contraceptive apparatus | ACTIVE | — |
| 035 | Surveys for business purposes; business research and surveys; market research and analysis services; collection of quality metric data for business purposes; compilation of statistical data relating to medical research for business purposes; business data analysis; data management, namely, management of data relating to data collection and data processing of samples of human waste for business purposes; data processing; computerised compilation of customer responses to surveys into computer databases for business purposes; compilation of lists of prospective customers into computer databases for business purposes; business management analysis; database management; retail store services featuring medical devices, medical apparatus, bags adapted for medical use, pharmaceutical preparations, sanitary preparations, medical supplies, veterinary preparations, chemicals, reagents; wholesale store services featuring medical devices, medical apparatus, bags adapted for medical use, pharmaceutical preparations, sanitary preparations, medical supplies, veterinary preparations, chemicals, reagents; electronic shopping retail services, namely, operating an on-line shopping site featuring medical devices, medical apparatus, bags adapted for medical use, pharmaceutical preparations, sanitary preparations, medical supplies, veterinary preparations, chemicals, reagents; retail store services provided online featuring medical devices, medical apparatus, bags adapted for medical use, pharmaceutical preparations, sanitary preparations, medical supplies, veterinary preparations, chemicals, reagents; retail store services provided by mail order featuring medical devices, medical apparatus, bags adapted for medical use, pharmaceutical preparations, sanitary preparations, medical supplies, veterinary preparations, chemicals, reagents; business consultancy, information and advisory services relating to customer surveys and medical research | ACTIVE | — |
| 038 | Interactive telecommunications services, namely, electronic exchange of data stored in databases accessible via telecommunication networks; online communications services, namely, providing on-line communications links which transfer the website user to other local and global web pages; telecommunications portal services, namely, transmission and reception of database information via the telecommunication network; providing access to online computer databases on the internet; providing access to multimedia content online; online document delivery via a global computer network; telecommunications services, namely, digital network telecommunications services, transmission of podcasts, and providing access to an internet discussion website; telecommunications gateway services; electronic data transmission; electronic exchange of data stored in databases accessible via telecommunication networks; consultancy, information and advisory services relating to telecommunications | ACTIVE | — |
| 042 | Clinical research in the fields of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies and gastrointestinal health; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; research and development in the field of therapeutics; research and development of pharmaceutical preparations and medicines; research and development in the field of diagnostic preparations; research and development in the field of microorganisms and cells; biological research, clinical research in the fields of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies, gastrointestinal health and medical research; biochemical research and analysis; bacteriological research and analysis; scientific and medical research services in the field of microbiome modulating therapeutics; laboratory analysis in the fields of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies and gastrointestinal health; laboratory analysis in the field of bacteriology; analysis of human excreta for medical research; microbiological testing for scientific and medical research services; scientific research and analysis in the field of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies and gastrointestinal health; scientific risk assessment, namely, prediction and assessment of health risks to the public in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; industrial analysis and research, namely, industrial design services ; analysis of product design, namely, product design and development in the field of medical devices and new pharmaceuticals; analysis of product development, namely testing of new product development for others; quality assessment, namely, quality evaluation for others in the field of new pharmaceuticals; database design; maintenance of software in database systems; online electronic data storage; cross-platform conversion of digital content into other forms of digital content; technical data analysis in the fields of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies and gastrointestinal health; consultancy, information and advisory services relating to research and development in the fields of microbiology, genetics, the human immune system, the human gut, microbiome modulating therapies and gastrointestinal health | ACTIVE | — |
| 044 | Medical services; medical examinations; medical analysis services for the diagnosis and treatment of persons; health assessment surveys; health risk assessment surveys being health assessment services; medical health assessment services; medical analysis services relating to the treatment of persons; medical care services relating to patient treatment; analysis of human tissues for medical treatment; diagnostic testing and analysis of human faeces services for medical purposes; analysis of human serum for medical treatment; analysis of human excreta for medical treatment; human serum donation services; donation of bodily fluids and human waste; donation of human excreta; behavioural analysis for medical purposes; psychological assessment services; providing online medical records for treatment purposes, namely, providing medical profiles and medical record analysis and assessments via a website, designed to provide custom tailored output about a patient's suitability for being a donor of faecal matter; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical consultancy, information and advisory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Enterobiotix Limited
- Other trademarks owned by Enterobiotix Limited
- Other trademarks owned by Enterobiotix Limited
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NUMBER 2
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 18, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 29, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 29, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 24, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 8, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 8, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 19, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 31, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 17, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 17, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 29, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 29, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 24, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 25, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 4, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 3, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 24, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 23, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |